NASDAQ:BBTX

Bambusa Therapeutics (BBTX) Stock Price, News & Analysis

$16.00 +0.45 (+2.89%)
As of 11/20/2026 04:00 PM Eastern

About Bambusa Therapeutics Stock (NASDAQ:BBTX)

Advanced

Key Stats

Today's Range
$15.21
▼
$16.69
50-Day Range
N/A
52-Week Range
$13.60
▼
$17.65
Volume
137,667 shs
Average Volume
374,353 shs
Market Capitalization
$815.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bambusa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing next-generation, long-acting precision bispecific antibodies designed to redefine standards of care in immunology and inflammation and fundamentally improve patient quality of life. Its pipeline includes BBT001, BBT002, BBT003 and BBT004. Bambusa Therapeutics, Inc. is based in BOSTON.

Receive BBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bambusa Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBTX Stock News Headlines

Wall Street Zen Upgrades Bambusa Therapeutics (NASDAQ:BBTX) to Hold
Financial legend: “This is bad, really bad...”
Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.tc pixel
See More Headlines

BBTX Stock Analysis - Frequently Asked Questions

Bambusa Therapeutics' stock was trading at $14.99 on October 30, 2026. Since then, BBTX stock has increased by 6.7% and is now trading at $16.00.

Bambusa Therapeutics (BBTX) raised $169 million in an initial public offering on Friday, October 30th 2026. The company issued 10,555,555 shares at a price of $15.00-$17.00 per share. BofA Securities, Evercore ISI, UBS Investment Bank and Cantor acted as the underwriters for the IPO.

Bambusa Therapeutics's quiet period expires on Wednesday, December 9th. Bambusa Therapeutics had issued 10,555,555 shares in its public offering on October 30th. The total size of the offering was $168,888,880 based on an initial share price of $16.00. During Bambusa Therapeutics' quiet period, underwriters and any insiders that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Shares of BBTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
11/22/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:BBTX
CIK
2044950
Fax
N/A
Employees
26
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
50,940,000
Free Float
N/A
Market Cap
$815.04 million
Optionable
N/A
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:BBTX) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners